Focus Partners Wealth Has $1.38 Million Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Focus Partners Wealth trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 142,975 shares of the pharmacy operator’s stock after selling 5,879 shares during the quarter. Focus Partners Wealth’s holdings in Walgreens Boots Alliance were worth $1,380,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the business. Ensign Peak Advisors Inc boosted its holdings in Walgreens Boots Alliance by 7.9% during the fourth quarter. Ensign Peak Advisors Inc now owns 334,030 shares of the pharmacy operator’s stock valued at $3,116,000 after acquiring an additional 24,427 shares during the period. Ethic Inc. boosted its holdings in Walgreens Boots Alliance by 55.7% during the fourth quarter. Ethic Inc. now owns 82,966 shares of the pharmacy operator’s stock valued at $774,000 after acquiring an additional 29,686 shares during the period. Deutsche Bank AG boosted its holdings in Walgreens Boots Alliance by 29.7% during the fourth quarter. Deutsche Bank AG now owns 6,125,374 shares of the pharmacy operator’s stock valued at $57,150,000 after acquiring an additional 1,403,357 shares during the period. Diligent Investors LLC boosted its holdings in Walgreens Boots Alliance by 87.2% during the fourth quarter. Diligent Investors LLC now owns 146,520 shares of the pharmacy operator’s stock valued at $1,367,000 after acquiring an additional 68,264 shares during the period. Finally, Colonial Trust Co SC boosted its holdings in Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,297 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

WBA has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, May 13th. They issued a “hold” rating for the company. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Stock Up 1.0%

Shares of WBA opened at $11.29 on Friday. The stock has a market cap of $9.76 billion, a price-to-earnings ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.17. The company has a 50-day moving average price of $11.02 and a two-hundred day moving average price of $10.36.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analysts’ expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.20 earnings per share. Equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Chairman Stefano Pessina acquired 832,258 shares of the company’s stock in a transaction dated Sunday, April 27th. The stock was bought at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the acquisition, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.